bioAffinity Technologies, Inc. (NASDAQ:BIAFW) Short Interest Up 7.1% in July

bioAffinity Technologies, Inc. (NASDAQ:BIAFW) saw a significant growth in short interest in July. As of July 15th, there was short interest totalling 1,500 shares, a growth of 7.1% from the June 30th total of 1,400 shares. Based on an average daily trading volume, of 1,100 shares, the days-to-cover ratio is currently 1.4 days.

bioAffinity Technologies Price Performance

Shares of BIAFW stock remained flat at $0.55 on Thursday. bioAffinity Technologies has a twelve month low of $0.05 and a twelve month high of $0.90. The company’s 50 day moving average is $0.48 and its two-hundred day moving average is $0.40.

bioAffinity Technologies Company Profile

bioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level.